Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-16-007716
Filing Date
2016-11-04
Accepted
2016-11-04 16:37:47
Documents
67
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT txmd-10q_093016.htm 10-Q 488678
2 THIRD AMENDMENT TO LEASE ex10-1.htm EX-10.1 110871
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 10205
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 9788
5 SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 4552
6 SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 5832
  Complete submission text file 0001387131-16-007716.txt   3390795

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT txmd-20160930.xml EX-101.INS 574261
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20160930.xsd EX-101.SCH 35128
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT txmd-20160930_cal.xml EX-101.CAL 57190
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT txmd-20160930_def.xml EX-101.DEF 141357
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20160930_lab.xml EX-101.LAB 296638
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20160930_pre.xml EX-101.PRE 225105
Mailing Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487
Business Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 161975628
SIC: 2834 Pharmaceutical Preparations